2015
DOI: 10.1037/pha0000041
|View full text |Cite
|
Sign up to set email alerts
|

Sex differences in drug abuse: Etiology, prevention, and treatment.

Abstract: This special issue exemplifies one of the major goals of the current editor of Experimental and Clinical Psychopharmacology (Dr. Suzette Evans): to increase the number of manuscripts that emphasize females and address sex differences. Taken together, these articles represent a broad range of drug classes and approaches spanning preclinical research to treatment to better understand the role of sex differences in drug abuse. While not all studies found sex differences, we want to emphasize that finding no sex d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…Treatment for substance use disorders is influenced by patient gender with women having more barriers to access, more severe problems at treatment entry, and lower rates of completion of substance use treatment . The rate of opioid abuse is also greater in women than in men . Women are more likely to use opioids consistent with their prescription instructions, are more likely to use via the intended route of administration, and are more likely than men to use opioids to cope with psychiatric symptoms and negative affect .…”
Section: Discussionmentioning
confidence: 99%
“…Treatment for substance use disorders is influenced by patient gender with women having more barriers to access, more severe problems at treatment entry, and lower rates of completion of substance use treatment . The rate of opioid abuse is also greater in women than in men . Women are more likely to use opioids consistent with their prescription instructions, are more likely to use via the intended route of administration, and are more likely than men to use opioids to cope with psychiatric symptoms and negative affect .…”
Section: Discussionmentioning
confidence: 99%
“…ical research, and therefore the evidence that drives their care is less robust" (p. 391). Furthermore, sex/gender similarities should be considered as important and interesting as sex/gender differences and should be treated as such in articles (Evans & Reynolds, 2015;Rutter et al, 2003). Specifically, a null finding or small effect size with regard to sex/gender data is equally important when the goals are a clear understanding of the etiology of psychopathology (Rutter et al, 2003) and reliable and valid assessment and treatment strategies across sex/gender.…”
Section: Representative Samples and Clear Sample Descriptionsmentioning
confidence: 99%
“…Yet, delineating sex and gender differences is important in continued efforts to assess and treat psychopathology effectively in all persons, as well as for the development of comprehensive etiological models (Eaton et al, 2012). Moreover, it is important to document differences and similarities (Evans & Reynolds, 2015), as both are vital to a full understanding of the etiology of psychopathology. Researchers in the broader health science community are calling on their colleagues to consider and accurately report sex and gender constructs at each stage of the research process (Day, Mason, Tannenbaum, & Rochon, 2017;Heidari, Babor, De Castro, Tort, & Curno, 2015).…”
mentioning
confidence: 99%
“…Research on gender differences in substance abuse has remained of interest for decades (Evans & Reynolds, 2015; Wilson, 1987b). This research is at its best when there are theory-driven hypotheses associated with gender to test.…”
Section: Future Directionsmentioning
confidence: 99%